| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +33,511,676 | 99% | $20.50 | +$686,900,186 |
| Sells | 9 | -198,265 | 0.59% | $19.48 | -$3,862,044 |
| Net | -8 | +33,313,411 | 99% | +$683,038,142 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Director, 10%+ Owner | $2,379,657,147 | +$686,900,186 | +41% | 12 Dec 2025 |
| Peter Salzmann | Chief Executive Officer, Director | $17,543,264 | -$1,142,829 | -6.1% | 16 Apr 2025 |
| Frank Torti | Director | $16,667,378 | 01 Apr 2025 | ||
| Julia G. Butchko | Chief Development Officer | $14,251,795 | 21 Aug 2024 | ||
| Mark S. Levine | Chief Legal Officer | $8,124,353 | 20 Nov 2024 | ||
| William L. Macias | Chief Medical Officer | $7,454,384 | -$99,649 | -1.3% | 19 Feb 2025 |
| Eva Renee Barnett | Chief Financial Officer | $5,907,965 | -$400,661 | -6.4% | 16 Apr 2025 |
| Melanie Gloria | Chief Operating Officer | $4,159,058 | -$298,237 | -6.7% | 20 Nov 2025 |
| Michael Geffner | Chief Medical Officer | $4,147,740 | -$310,958 | -7% | 22 Oct 2025 |
| Christopher Van Tuyl | Chief Legal Officer | $4,105,083 | -$290,943 | -6.6% | 18 Dec 2025 |
| Jay Stout | Chief Technology Officer | $3,821,490 | -$296,142 | -7.2% | 22 Oct 2025 |
| Tiago Girao | Chief Financial Officer | $3,059,135 | 01 May 2025 | ||
| Douglas J. Hughes | Director | $2,893,721 | -$348,665 | -11% | 01 Dec 2025 |
| GEORGE V. MIGAUSKY | Director | $2,739,530 | 01 Apr 2025 | ||
| Atul Pande | Director | $2,452,106 | 01 Apr 2025 | ||
| Andrew J. Fromkin | Director | $2,056,155 | -$673,958 | -25% | 01 Dec 2025 |
| Robert Susman | Director | $367,234 | 01 May 2025 | ||
| Jake Bauer | Director | $367,234 | 01 May 2025 | ||
| Eric Venker | Chief Executive Officer, Director | 28 Jul 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|